[Relationship between plasma levels of thrombin activatable fibrinolysis inhibitor, plasminogen activator inhibitor-1 and tissue-type plasminogen activator and deep venous thrombosis in patients with systemic lupus erythematosus].

Liu, Y F; Hou, N; Shi, Y J; Li, C X; Gao, Y J; Liu, L N

Liu, Y F; Hou, N; Shi, Y J; Li, C X; Gao, Y J; Liu, L N.

Afiliación

Liu YF; Department of Rheumatology and Immunology, Liaocheng People's Hospital of Shandong Province, Liaocheng 252000, China.
Hou N; Department of Rheumatology and Immunology, Liaocheng People's Hospital of Shandong Province, Liaocheng 252000, China.
Shi YJ; Department of Rheumatology and Immunology, Liaocheng People's Hospital of Shandong Province, Liaocheng 252000, China.
Li CX; Department of Rheumatology and Immunology, Liaocheng People's Hospital of Shandong Province, Liaocheng 252000, China.
Gao YJ; Department of Laboratory Medicine, Liaocheng People's Hospital of Shandong Province, Liaocheng 252000, China.
Liu LN; Department of Rheumatology and Immunology, Liaocheng People's Hospital of Shandong Province, Liaocheng 252000, China.

Zhonghua Yi Xue Za Zhi ; 103(21): 1638-1642, 2023 Jun 06.

Article en Zh | MEDLINE | ID: mdl-37248064

Asunto(s)

Carboxipeptidasa B2; Trombosis; Trombosis de la Vena; Masculino; Femenino; Humanos; Adulto; Persona de Mediana Edad; Inhibidor 1 de Activador Plasminogénico; Activador de Tejido Plasminógeno; Estudios de Casos y Controles; Estudios Retrospectivos; Fibrinólisis

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Trombosis / Trombosis de la Vena / Carboxipeptidasa B2 Tipo de estudio: Observational_studies / Prognostic_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: Zh Revista: Zhonghua Yi Xue Za Zhi Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google